The selection of a dependable manufacturer for critical pharmaceutical intermediates like L-N-Butylsulfonyl-P-Hydroxyphenylalanine (CAS 149490-60-8) is a decision that can profoundly impact a company's research and production timelines. This compound is primarily recognized for its role as an intermediate in the synthesis of Tirofiban, a key drug used in managing acute coronary syndromes. Therefore, ensuring the quality and consistency of this material is paramount for pharmaceutical R&D scientists and procurement teams.

When evaluating potential suppliers, particularly those based in China, several key factors should be prioritized. Firstly, the purity of the L-N-Butylsulfonyl-P-Hydroxyphenylalanine is critical; manufacturers often quote purity levels of 98% or higher. Secondly, a manufacturer's production capacity and their ability to deliver consistently are essential for maintaining a stable supply chain. Companies looking to buy this intermediate should also consider the supplier's responsiveness and their willingness to provide comprehensive technical documentation, such as Certificates of Analysis (CoA) and Safety Data Sheets (SDS).

Price is, of course, a significant consideration. Competitive pricing, especially for bulk orders, can significantly reduce manufacturing costs. However, it should always be weighed against quality and reliability. A manufacturer offering a slightly higher price but demonstrating superior quality control and a proven track record of timely delivery is often a more advantageous partner.

Ultimately, choosing the right manufacturer for CAS 149490-60-8 involves a thorough vetting process. By focusing on quality, consistency, and a strong commitment to customer support, pharmaceutical companies can secure a reliable source for this vital intermediate, ensuring the successful development and production of essential therapeutic agents.